ID   ERR1_RAT                Reviewed;         422 AA.
AC   Q5QJV7; Q3MHT1;
DT   10-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   10-JUL-2007, sequence version 2.
DT   02-OCT-2024, entry version 140.
DE   RecName: Full=Steroid hormone receptor ERR1;
DE   AltName: Full=Estrogen-related receptor alpha;
DE            Short=ERR-alpha;
DE   AltName: Full=Nuclear receptor subfamily 3 group B member 1;
GN   Name=Esrra; Synonyms=Nr3b1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Lui K., Chen S., Chan F.L.;
RT   "Molecular cloning and expression study of estrogen receptor-related
RT   receptor alpha in rat ovary.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Binds to an ERR-alpha response element (ERRE) containing a
CC       single consensus half-site, 5'-TNAAGGTCA-3'. Can bind to the medium-
CC       chain acyl coenzyme A dehydrogenase (MCAD) response element NRRE-1 and
CC       may act as an important regulator of MCAD promoter. Binds to the C1
CC       region of the lactoferrin gene promoter. Requires dimerization and the
CC       coactivator, PGC-1A, for full activity. The ERRalpha/PGC1alpha complex
CC       is a regulator of energy metabolism. Induces the expression of PERM1 in
CC       the skeletal muscle.
CC   -!- SUBUNIT: Binds DNA as a monomer or a homodimer. Interacts (via the AF2
CC       domain) with coactivator PPARGC1A (via the L3 motif); the interaction
CC       greatly enhances transcriptional activity of genes involved in energy
CC       metabolism. Interacts with PIAS4; the interaction enhances sumoylation
CC       (By similarity). Interacts with MAPK15; promotes re-localization of
CC       ESRRA to the cytoplasm through a XPO1-dependent mechanism then inhibits
CC       ESRRA transcriptional activity (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P11474}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P11474,
CC       ECO:0000255|PROSITE-ProRule:PRU00407}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P11474}. Note=Co-localizes to the cytoplasm only
CC       in presence of MAPK15. {ECO:0000250|UniProtKB:P11474}.
CC   -!- PTM: Phosphorylation on Ser-19 enhances sumoylation on Lys-14
CC       increasing repression of transcriptional activity. {ECO:0000250}.
CC   -!- PTM: Sumoylated with SUMO2. Main site is Lys-14 which is enhanced by
CC       phosphorylation on Ser-19, cofactor activation, and by interaction with
CC       PIAS4. Sumoylation enhances repression of transcriptional activity, but
CC       has no effect on subcellular location nor on DNA binding (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Reversibly acetylated. Acetylation by PCAF/KAT2 at Lys-129, Lys-
CC       138, Lys-160 and Lys-162 and PCAF/KAT2 decreases transcriptional
CC       activity probably by inhibiting DNA-binding activity; deacetylation
CC       involves SIRT1 and HDAC8 and increases DNA-binding (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI04702.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAQ17212.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY280663; AAQ17212.1; ALT_FRAME; mRNA.
DR   EMBL; BC104701; AAI04702.1; ALT_INIT; mRNA.
DR   RefSeq; NP_001008511.2; NM_001008511.2.
DR   AlphaFoldDB; Q5QJV7; -.
DR   SMR; Q5QJV7; -.
DR   BioGRID; 254410; 1.
DR   STRING; 10116.ENSRNOP00000028697; -.
DR   iPTMnet; Q5QJV7; -.
DR   PhosphoSitePlus; Q5QJV7; -.
DR   jPOST; Q5QJV7; -.
DR   PaxDb; 10116-ENSRNOP00000028697; -.
DR   GeneID; 293701; -.
DR   KEGG; rno:293701; -.
DR   UCSC; RGD:1583866; rat.
DR   AGR; RGD:1583866; -.
DR   CTD; 2101; -.
DR   RGD; 1583866; Esrra.
DR   VEuPathDB; HostDB:ENSRNOG00000021139; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   HOGENOM; CLU_007368_11_0_1; -.
DR   InParanoid; Q5QJV7; -.
DR   OrthoDB; 5387678at2759; -.
DR   PhylomeDB; Q5QJV7; -.
DR   TreeFam; TF323751; -.
DR   Reactome; R-RNO-383280; Nuclear Receptor transcription pathway.
DR   PRO; PR:Q5QJV7; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000021139; Expressed in duodenum and 19 other cell types or tissues.
DR   ExpressionAtlas; Q5QJV7; baseline and differential.
DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0034056; F:estrogen response element binding; IBA:GO_Central.
DR   GO; GO:0004879; F:nuclear receptor activity; IBA:GO_Central.
DR   GO; GO:0003707; F:nuclear steroid receptor activity; IEA:InterPro.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0005496; F:steroid binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0051216; P:cartilage development; IMP:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0030518; P:nuclear receptor-mediated steroid hormone signaling pathway; IBA:GO_Central.
DR   GO; GO:1900078; P:positive regulation of cellular response to insulin stimulus; IMP:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0030278; P:regulation of ossification; IMP:RGD.
DR   GO; GO:0045667; P:regulation of osteoblast differentiation; IMP:RGD.
DR   GO; GO:0045670; P:regulation of osteoclast differentiation; IMP:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   CDD; cd07170; NR_DBD_ERR; 1.
DR   CDD; cd06946; NR_LBD_ERR; 1.
DR   Gene3D; 3.30.50.10; Erythroid Transcription Factor GATA-1, subunit A; 1.
DR   Gene3D; 1.10.565.10; Retinoid X Receptor; 1.
DR   InterPro; IPR024178; Est_rcpt/est-rel_rcp.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR050200; Nuclear_hormone_rcpt_NR3.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR027289; Oest-rel_rcp.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   PANTHER; PTHR48092; KNIRPS-RELATED PROTEIN-RELATED; 1.
DR   PANTHER; PTHR48092:SF15; STEROID HORMONE RECEPTOR ERR1; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PIRSF; PIRSF002527; ER-like_NR; 1.
DR   PIRSF; PIRSF500939; ERR1-2-3; 1.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 1.
DR   SUPFAM; SSF48508; Nuclear receptor ligand-binding domain; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; DNA-binding; Isopeptide bond; Metal-binding;
KW   Nucleus; Phosphoprotein; Receptor; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..422
FT                   /note="Steroid hormone receptor ERR1"
FT                   /id="PRO_0000295232"
FT   DOMAIN          192..420
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        76..151
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         79..99
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         115..134
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          1..76
FT                   /note="Repressor domain"
FT                   /evidence="ECO:0000250"
FT   REGION          1..66
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          402..422
FT                   /note="AF-2 domain"
FT                   /evidence="ECO:0000250"
FT   SITE            124
FT                   /note="Required for DNA-dependent dimerization"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         19
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         22
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11474"
FT   MOD_RES         129
FT                   /note="N6-acetyllysine; by PCAF/KAT2B"
FT                   /evidence="ECO:0000250|UniProtKB:P11474"
FT   MOD_RES         138
FT                   /note="N6-acetyllysine; by PCAF/KAT2B"
FT                   /evidence="ECO:0000250|UniProtKB:P11474"
FT   MOD_RES         160
FT                   /note="N6-acetyllysine; by PCAF/KAT2B"
FT                   /evidence="ECO:0000250|UniProtKB:P11474"
FT   MOD_RES         162
FT                   /note="N6-acetyllysine; by PCAF/KAT2B"
FT                   /evidence="ECO:0000250|UniProtKB:P11474"
FT   CROSSLNK        14
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        189
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11474"
FT   CROSSLNK        402
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        402
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11474"
SQ   SEQUENCE   422 AA;  45464 MW;  2F54EEA1BD3B511D CRC64;
     MSSQVVGIEP LYIKAEPASP DSPKGSSETE TEPPVTLASG PAPARCLPGH KEEEDGEGAG
     SGEQGSGKLV LSSLPKRLCL VCGDVASGYH YGVASCEACK AFFKRTIQGS IEYSCPASNE
     CEITKRRRKA CQACRFTKCL RVGMLKEGVR LDRVRGGRQK YKRRPEVDPL PFPGPFPAGP
     LAVAGGPRKT APVNALVSHL LVVEPEKLYA MPDPASPDGH LPAVATLCDL FDREIVVTIS
     WAKSIPGFSS LSLSDQMSVL QSVWMEVLVL GVAQRSLPLQ DELAFAEDLV LDEEGARAAG
     LGDLGAALLQ LVRRLQALRL EREEYVLLKA LALANSDSVH IEDAEAVEQL REALHEALLE
     YEAGRAGPGG GAERRRAGRL LLTLPLLRQT AGKVLAHFYG VKLEGKVPMH KLFLEMLEAM
     MD
//
